Jiangsu Nhwa Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Jiangsu Nhwa Pharmaceutical Co Ltd cash flow reinvestment rate. Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a Cash Flow Reinvestment Rate of 0.19x as of September 2025, reinvesting CN¥80.95 Million (capex CN¥80.95 Million ) from operating cash flow of CN¥425.83 Million. Explore 002262 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)
Cash flow reinvestment rate of Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2025. Historical reinvestment intensity for Jiangsu Nhwa Pharmaceutical Co Ltd across 21 annual periods. Explore 002262 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Jiangsu Nhwa Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2005–2025)
Jiangsu Nhwa Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2005 to 2025. Year-by-year capital reinvestment analysis for Jiangsu Nhwa Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Jiangsu Nhwa Pharmaceutical Co Ltd (002262) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.43x | CN¥458.62 Million | CN¥1.08 Billion | CN¥437.41 Million | ▼ -21.5% |
| 2024 | 0.54x | CN¥496.18 Million | CN¥916.13 Million | CN¥450.06 Million | ▼ -18.2% |
| 2023 | 0.66x | CN¥667.38 Million | CN¥1.01 Billion | CN¥373.99 Million | ▼ -43.9% |
| 2022 | 1.18x | CN¥1.02 Billion | CN¥861.02 Million | CN¥327.75 Million | ▲ +93.6% |
| 2021 | 0.61x | CN¥427.51 Million | CN¥701.12 Million | CN¥206.11 Million | ▼ -19.5% |
| 2020 | 0.76x | CN¥945.61 Million | CN¥1.25 Billion | CN¥268.61 Million | ▼ -54.1% |
| 2019 | 1.65x | CN¥505.30 Million | CN¥305.97 Million | CN¥160.30 Million | ▲ +96.7% |
| 2018 | 0.84x | CN¥339.65 Million | CN¥404.52 Million | CN¥170.70 Million | ▼ -0.6% |
| 2017 | 0.84x | CN¥382.01 Million | CN¥452.35 Million | CN¥166.01 Million | ▼ -31.3% |
| 2016 | 1.23x | CN¥340.68 Million | CN¥277.14 Million | CN¥102.22 Million | ▼ -33.7% |
| 2015 | 1.85x | CN¥378.75 Million | CN¥204.24 Million | CN¥216.63 Million | ▲ +13.6% |
| 2014 | 1.63x | CN¥261.60 Million | CN¥160.24 Million | CN¥261.60 Million | ▲ +206.2% |
| 2013 | 0.53x | CN¥103.63 Million | CN¥194.33 Million | CN¥103.63 Million | ▲ +5.4% |
| 2012 | 0.51x | CN¥78.01 Million | CN¥154.16 Million | CN¥78.01 Million | ▼ -11.2% |
| 2011 | 0.57x | CN¥46.21 Million | CN¥81.08 Million | CN¥46.21 Million | ▼ -58.8% |
| 2010 | 1.38x | CN¥85.57 Million | CN¥61.79 Million | CN¥85.57 Million | ▲ +101.3% |
| 2009 | 0.69x | CN¥42.15 Million | CN¥61.27 Million | CN¥42.15 Million | ▼ -14.5% |
| 2008 | 0.80x | CN¥37.40 Million | CN¥46.50 Million | CN¥37.40 Million | ▼ -6.9% |
| 2007 | 0.86x | CN¥41.96 Million | CN¥48.55 Million | CN¥41.96 Million | ▼ -25.8% |
| 2006 | 1.16x | CN¥36.09 Million | CN¥30.99 Million | CN¥36.09 Million | ▼ -67.8% |
| 2005 | 3.62x | CN¥31.99 Million | CN¥8.84 Million | CN¥31.99 Million | — |